Discontinued — last reported Q4 '25
Deferred Taxes
OperatingEli Lilly Deferred Taxes increased by 249.2% to $748.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 22.6%, from $966.70M to $748.10M. Over 4 years (FY 2021 to FY 2025), Deferred Taxes shows an upward trend with a 20.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2007
Last reportedQ4 2025
How to read this metric
A large deferred tax benefit (negative value) may signal future cash outflows, while a deferred tax expense (positive value) suggests cash savings today.
Detailed definition
The difference between the income tax expense reported on the financial statements and the actual taxes paid to authorit...
Peer comparison
Multinational corporations often have complex deferred tax profiles due to varying international tax jurisdictions.
Metric ID:
cf_deferred_income_taxesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $294.70M | $296.00M | $92.50M | $506.60M | $618.40M | $1.07B | $0.00 | $559.40M | $431.10M | $844.30M | $506.20M | $279.00M | $1.01B | $429.80M | $966.70M | $391.60M | $1.07B | -$501.40M | $748.10M |
| QoQ Change | — | +0.4% | -68.8% | +447.7% | +22.1% | +73.1% | -100.0% | — | -22.9% | +95.8% | -40.0% | -44.9% | +261.1% | -57.3% | +124.9% | -59.5% | +172.9% | -146.9% | +249.2% |
| YoY Change | — | — | — | — | +109.8% | +261.7% | -100.0% | +10.4% | -30.3% | -21.1% | — | -50.1% | +133.7% | -49.1% | +91.0% | +40.4% | +6.1% | -216.7% | -22.6% |
Range-$501.40M – $1.07B
CAGR+23.0%
Avg YoY Growth+11.7%
Median YoY Growth-7.5%
Deferred Taxes at Other Companies
Frequently Asked Questions
- What is Eli Lilly's deferred taxes?
- Eli Lilly (LLY) reported deferred taxes of $748.10M in Q4 2025.
- How has Eli Lilly's deferred taxes changed year-over-year?
- Eli Lilly's deferred taxes decreased by 22.6% year-over-year, from $966.70M to $748.10M.
- What is the long-term trend for Eli Lilly's deferred taxes?
- Over 4 years (2021 to 2025), Eli Lilly's deferred taxes has grown at a 20.8% compound annual growth rate (CAGR), from $802.30M to $1.71B.
- What does deferred taxes mean?
- Taxes that are recorded on the books now but will be paid or saved in the future.